/Investor DB

Forbion — 2016 Investments

2 investments dated 2016 · listed companies and verified rows first · show all

ViCentravicentra.comSeries B · Jan 2016 · $11M

Kaleido, a lightweight modular precision-dosing insulin pump.

Co-investorsInkefInnovation IndustriesEQT Life SciencesInvest-NLROM Utrecht Region

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Nightbalance

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.